Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study

Glioblastoma (GBM) is an incurable brain tumor for which new treatment strategies are urgently needed. Next‐generation sequencing of GBM has most often been performed retrospectively and on archival tissue from both diagnostic and relapse surgeries with limited knowledge of clinical information, inc...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Dorte S. Nørøxe, Christina W. Yde, Olga Østrup, Signe R. Michaelsen, Ane Y. Schmidt, Savvas Kinalis, Mathias H. Torp, Jane Skjøth‐Rasmussen, Jannick Brennum, Petra Hamerlik, Hans S. Poulsen, Finn C. Nielsen, Ulrik Lassen
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2020-11-01
סדרה:	Molecular Oncology
נושאים:	chromosomal instability genomic profiling newly diagnosed glioblastoma NTRK fusion translational relevance tumor mutational burden
גישה מקוונת:	https://doi.org/10.1002/1878-0261.12790
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!